Summary

1. Lilly should be pleased with approval of Strattera in children and adolescents 2. Strattera is the superior agent for ADHD 3. approval should boost Liily sales

Analysis

 Lilly should be pleased with approval of Strattera in children and adolescents. Strattera is the superior agent for ADHD and the approval should boost Liily sales of Strattera. As ADHD ids probably a life long condition a non stimulating agent like strattera is ideal for daily therapy. Many children are upset if other children know they take medication for ADHD. Strattera is superior because it works well with few side effects and is once a day.  

                                   Dr Spurlock

John Spurlock consults with leading institutions through GLG

John Spurlock, Medical Director

What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Medical Director, Continence Management Institute of the LeHigh Valley

 
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.